NCT00260039 - Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001) | Biotech Hunter

Enrollment

680

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

August 31, 2007

Study Completion Date

August 31, 2007

Conditions

HPVCervical CancerPremalignancy Anogenital Warts

Interventions

BIOLOGICAL

Comparator: Gardasil

0.5 mL intramuscular injection administered at Day 1, Month 2 and Month 6

BIOLOGICAL

Comparator: octavalent HPV Vaccine - dose formulation 1

0.5 mL octavalent HPV vaccine - intramuscular injection administered at Day 1, Month 2 and Month 6

BIOLOGICAL

Comparator: octavalent HPV Vaccine - dose formulation 2

0.5 mL octavalent HPV vaccine - intramuscular injection administered at Day 1, Month 2 and Month 6

BIOLOGICAL

Comparator: octavalent HPV Vaccine - dose formulation 3

0.5 mL octavalent HPV vaccine - intramuscular injection administered at Day 1, Month 2 and Month 6

All Listed Sponsors

lead

Merck Sharp & Dohme LLC

INDUSTRY